Skip to content

Clinical trials

Lupus Nephritis trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Nephritis Country / region: Hong Kong Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20101
20123
20132
20151
20163
20171
20182
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated6
Recruiting3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The University of Hong Kong5
Novartis Pharmaceuticals4
Biogen2
Boehringer Ingelheim2
Chinese University of Hong Kong2
Bristol-Myers Squibb1
Human Genome Sciences Inc., a GSK Company1
La Jolla Pharmaceutical Company1
Omeros Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Nephritis19
Lupus Erythematosus, Systemic6
Glomerulonephritis3
Nephritis3
Autoimmune Diseases1
Glomerulonephritis, IGA1
Glomerulonephritis, Membranous1
Kidney Diseases1
Proteinuria1
Renal Insufficiency, Chronic1

Trials

Showing 51 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.